Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Cancer Pharmacology, Early Phase Trials

Howard A. Burris III

MD

🏢Sarah Cannon Research Institute🌐USA

President and Chief Medical Officer

95
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Howard Burris has led some of the most productive phase I oncology programs in the United States and has contributed to the early development of numerous approved cancer drugs. He served as ASCO president and is widely recognized for his leadership in clinical drug development. His work has shaped modern phase I practice.

Share:

🧪Research Fields 研究领域

phase I trials
drug development
targeted therapy
clinical pharmacology
oncology leadership

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Howard A. Burris III 的研究动态

Follow Howard A. Burris III's research updates

留下邮箱,当我们发布与 Howard A. Burris III(Sarah Cannon Research Institute)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment